Contemporary Issues in Lung CancerJones & Bartlett Publishers, 2009 M02 12 - 364 pages In the United States, lung cancer is the second most commonly diagnosed cancer and the leading cause of cancer death. Even more devastating is its five-year survival rate of only 15.8%. Despite these dismal facts, lung cancer receives little national attention and research and funding for lung cancer lags behind other cancers. The intent of Contemporary Issues in Lung Cancer: A Nursing Perspective Second Edition is to provide oncology nurses and healthcare professionals with in-depth information on the issues that surround this disease, so that they might impact both education and research and provide better care for their patients. |
From inside the book
Results 1-5 of 70
Page ix
... role that combined chemotherapy plays in treating this disease are discussed in depth. The chapters in Part Three address the special issues that face lung cancer patients: fatigue, end of life, nutrition, dyspnea, and radon exposure ...
... role that combined chemotherapy plays in treating this disease are discussed in depth. The chapters in Part Three address the special issues that face lung cancer patients: fatigue, end of life, nutrition, dyspnea, and radon exposure ...
Page 12
... role of nutrients in the etiology of lung cancer is confounded by num- erous methodological problems and the con- flicting data in these studies (Ginsberg, Kris, & Armstrong, 1993). It is hypothesized that ca- rotenoids, vitamins C and ...
... role of nutrients in the etiology of lung cancer is confounded by num- erous methodological problems and the con- flicting data in these studies (Ginsberg, Kris, & Armstrong, 1993). It is hypothesized that ca- rotenoids, vitamins C and ...
Page 21
... role in lung development and repair, as well as the promotion of lung cancer (Sekido, et al., 2005). Studies have demonstrated that GRP is expressed in 20–60% of SCLC but less frequently in NSCLC (Sekido, et al., 2005). A signaling ...
... role in lung development and repair, as well as the promotion of lung cancer (Sekido, et al., 2005). Studies have demonstrated that GRP is expressed in 20–60% of SCLC but less frequently in NSCLC (Sekido, et al., 2005). A signaling ...
Page 23
... role of p16INK4A is to maintain a cycle by keeping RB unphosphory- lated. Thus, if mutation of p16INK4A occurs, the cycle cannot be restrained. Often p16INK4A is abnormal in human malignancy (Sekido, et al., 2005). In NSCLC, p16INK4A is ...
... role of p16INK4A is to maintain a cycle by keeping RB unphosphory- lated. Thus, if mutation of p16INK4A occurs, the cycle cannot be restrained. Often p16INK4A is abnormal in human malignancy (Sekido, et al., 2005). In NSCLC, p16INK4A is ...
Page 24
... role in lung cancer. Other potential targets are TSLC1, which is located at 11q23, and MYO18B at 22q12 (Sekido, et al., 2005). The frequent loss of alleles has been identified on chromosomes in lung cancer. This chromosome-acquired loss ...
... role in lung cancer. Other potential targets are TSLC1, which is located at 11q23, and MYO18B at 22q12 (Sekido, et al., 2005). The frequent loss of alleles has been identified on chromosomes in lung cancer. This chromosome-acquired loss ...
Contents
Oncology Treatment Modalities | 45 |
Special Issues Facing Individuals with Lung Cancer | 117 |
Psychosocial Issues of Individuals with Lung Cancer | 231 |
Assistance and Resources for Individuals Facing Lung Cancer | 255 |
Media and Future Research Directions | 301 |
Index | 353 |
Other editions - View all
Common terms and phrases
adjuvant agents aprepitant associated bevacizumab breathing breathlessness Bruera carboplatin carcinoma cell lung cancer chemotherapy chronic cisplatin Clinical Oncology clinical trials combination diagnosis disease docetaxel dose drug dyspnea EGFR erlotinib etoposide evaluation evidence-based factors fatigue gefitinib gemcitabine gene improve increased individuals indoor radon Internet intervention irinotecan Journal of Clinical lung cancer patients Medicine ment metastatic months NCCN nicotine non-small cell lung NSCLC Nursing Forum Oncology Nursing Oncology Nursing Forum paclitaxel palliative palliative care patient navigation patients and families patients with lung pemetrexed phase postoperative potential pulmonary quit smoking radiation therapy radiotherapy radon randomized receptors regimen reported resection respiratory response rate risk role SCLC score screening Sekido side effects small cell lung smoking cessation stage strategies support group surgical survival rate Symptom Management Table tients tion tobacco topotecan toxicity treat treatment tumor versus vinorelbine weight loss